Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
British Journal of Haematology|November 15, 2020
CAR-T cell therapy in paediatric acute lymphoblastic leukaemia - past, present and futureSrdan Rogosic, Sara GhorashianHematology. American Society of Hematology. Education Program|December 5, 2025
Maintenance after CAR T? Are we there yet? Reducing the risk of relapse after loss of anti-CD19 CAR T-cell persistence in ALLMaria Gabelli, Sara GhorashianBlood Cancer Discovery|January 12, 2022
Rare Sequences Make Sense of CAR T-cell Therapy OutcomesSara Ghorashian, Jack BartramBlood Reviews|October 27, 2004
"Off-license" use of recombinant activated factor VIISara Ghorashian, Beverley J HuntBritish Journal of Haematology|March 11, 2015
CD19 chimeric antigen receptor T cell therapy for haematological malignanciesSara Ghorashian, Martin Pule, Persis AmroliaAdvances in Hematology|February 10, 2012
Improving TCR Gene Therapy for Treatment of Haematological MalignanciesEmma Nicholson, Sara Ghorashian, Hans StaussExperimental Hematology|July 23, 2018
Open access? Widening access to chimeric antigen receptor (CAR) therapy for ALLSara Ghorashian, Persis Amrolia, Paul VeysBest Practice & Research. Clinical Haematology|September 20, 2011
T cell gene-engineering to enhance GVT and suppress GVHDSara Ghorashian, Emma Nicholson, Hans J StaussCurrent Opinion in Biotechnology|February 21, 2018
A guide to manufacturing CAR T cell therapiesPhilipp Vormittag, Rebecca Gunn, Sara Ghorashian, et al.Bulletin of the World Health Organization|November 28, 2006
Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the CongoManica Balasegaram, Steve Harris, Francesco Checchi, et al.Pageof 5